Among these seven genes, AP3B1, ONECUT2, and IL-6 were already confirmed to be the direct targets of miR-9 [15–17]; ANXA2 and IL-6 are well-established oncogenes in HCC [30–32]. This evidence concerns the gene ANXA2 and hepatocellular carcinoma.